Examines protein yield and product quality in cellular agriculture, suggesting innovative solutions.
, are critically evaluated regarding protein yield, product quality, regulatory suitability, downstream processing, and techno-economic feasibility. Industrial-scale fermentation capacities up to 80,000 L demonstrate the growing potential for large-scale recombinant protein production. Applications of recombinant proteins in edible scaffolds, serum-free culture media, extracellular matrix alternatives, and functional food ingredients are discussed alongside their associated technical and regulatory challenges. Ultimately, recombinant proteins are identified as integrative elements bridging acellular and cell-based production systems, supporting the development of scalable, economically viable, and sustainable cellular agriculture.
No takes yet. Share an insight, caveat, or question.
Jadhav et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: